Magnesium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulfate ## Overview Magnesium sulfate is an essential mineral that plays a crucial role in numerous biochemical reactions within the body. It acts as a cofactor for enzymes, influences neuromuscular transmission, and is involved in myocardial function. ## Primary Indications * **Eclampsia/Preeclampsia:** Prevention and treatment of seizures associated with severe preeclampsia and eclampsia. * **Hypomagnesemia:** Treatment of low magnesium levels in patients with or without cardiac symptoms. * **Torsades de Pointes:** Treatment of polymorphic ventricular tachycardia (Torsades de Pointes), especially when associated with a prolonged QT interval. * **Bronchospasm:** Adjunctive treatment for severe, life-threatening bronchospasm in asthma or COPD, particularly when unresponsive to standard therapies. ## Adult Dosing * **Eclampsia/Preeclampsia (loading dose):** 4-6 grams intravenously (IV) over 5-20 minutes. * **Eclampsia/Preeclampsia (maintenance dose):** 1-2 grams IV per hour. Adjust based on clinical response and magnesium levels. * **Hypomagnesemia (severe, life-threatening):** 4-8 grams IV loading dose, followed by a maintenance infusion. Exact dosing should be guided by serum magnesium levels and clinical presentation. * **Hypomagnesemia (less severe):** Typically 1-2 grams IV per hour. * **Hypomagnesemia (oral):** May be used for less severe cases or as oral supplementation; doses vary widely (e.g., 200-400 mg elemental magnesium daily in divided doses). * **Torsades de Pointes:** 1-2 grams IV in 10 mL of D5W, administered IV push over 5-10 minutes. May repeat doses, followed by an infusion of 0.5-1 gram per hour. * **Bronchospasm (adjunctive):** 2 grams IV infused over 15-30 minutes. ## Pediatric Dosing Dosing for pediatric patients is highly variable and should be guided by specific protocols, serum magnesium levels, and clinical indication. * **Hypomagnesemia:** Dosing is typically based on weight and serum magnesium levels. Common loading doses range from 25-50 mg/kg IV, with maintenance doses of 10-25 mg/kg/hr. * **Eclampsia/Preeclampsia:** Less common in pediatrics, but similar principles to adults may apply, with doses adjusted for weight and age. * **Torsades de Pointes:** Dosing similar to adults, adjusted for weight, often 25-50 mg/kg IV maximum 2 grams per dose. ## Dose Adjustments * **Renal Impairment:** Magnesium is renally excreted. In patients with significant renal impairment, reduce the dose and monitor magnesium levels closely to prevent hypermagnesemia. ## Contraindications * Hypermagnesemia * Heart block (unless a pacemaker is in place) * Myocardial infarction * Addison's disease * Anuria or significant renal impairment (relative contraindication, requires dose adjustment) ## Adverse Effects * **Common:** Flushing, warmth, diaphoresis, hypotension, nausea, vomiting, somnolence, decreased deep tendon reflexes. * **Serious:** Respiratory depression, cardiac arrest, hypermagnesemia (leading to CNS depression, neuromuscular paralysis, hypotension, and cardiac arrhythmias). ## Key Drug Interactions * **Neuromuscular Blockers:** Magnesium can potentiate the effects of neuromuscular blocking agents, leading to prolonged neuromuscular blockade. * **Calcium Channel Blockers:** Additive hypotensive effects and potential for bradycardia or heart block. * **Tetracyclines and Quinolones:** Magnesium can decrease the absorption of oral tetracyclines and fluoroquinolones. Separate administration by at least 2-3 hours. * **Digoxin:** May increase the risk of digoxin toxicity in hypomagnesemic states. ## Monitoring * **Serum Magnesium Levels:** Essential for guiding dosing, especially with IV administration, and for assessing efficacy and toxicity. Target levels vary by indication but are often 4-7 mEq/L for eclampsia. * **Renal Function:** Monitor creatinine and BUN, especially in patients with impaired renal function. * **Deep Tendon Reflexes:** Loss of reflexes is an early sign of hypermagnesemia. * **Respiratory Rate and Effort:** Monitor for signs of respiratory depression. * **Blood Pressure and Heart Rate:** Monitor for hypotension and bradycardia. * **Urine Output:** Adequate urine output is necessary for magnesium excretion. ## Clinical Pearls * Magnesium sulfate is administered as a solution containing approximately 50% elemental magnesium by weight. Always calculate doses based on elemental magnesium needs or the specific salt form. * IV administration can cause flushing and a feeling of warmth. Administer IV infusions slowly to minimize these effects and reduce the risk of hypotension. * In hypomagnesemic patients, correcting magnesium levels can improve refractoriness to certain medications (e.g., potassium repletion, digoxin therapy). * When treating Torsades de Pointes, magnesium should be administered regardless of the baseline magnesium level. *** *Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always verify current prescribing information with the official drug labeling and consult with a qualified healthcare professional for patient-specific guidance.*